Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285603433> ?p ?o ?g. }
- W4285603433 endingPage "101342" @default.
- W4285603433 startingPage "101342" @default.
- W4285603433 abstract "Cancer affects older adults with varying levels of frailty, but cancer treatment is extrapolated from clinical trials involving predominantly young and robust subjects. Recent geriatric oncology randomised controlled trials (RCT) report that geriatric assessment leading to frailty-guided intervention reduces treatment-related toxicity whilst maintaining survival and improving quality of life (QoL). However, these positive results have not have been consistently reported in the literature. We postulate that the impact of geriatric interventions has been underestimated in these studies with the inclusion of subjects receiving palliative-intent chemotherapy in whom dose reduction is common. Integrating supportive care with current geriatric oncology models may improve the QoL of older adults undergoing treatment. However, no studies as yet have examined such integrated geriatric and supportive models of care. The Geriatric Oncology SuPportive clinic for Elderly (GOSPEL) study is a single-centre, open-label, analyst-blinded RCT evaluating the impact of comprehensive geriatric and supportive care on QoL of older adults with cancer undergoing curative treatment. Older adults aged above 65, with a Geriatric-8 score ≤ 14, with plans for high dose radiotherapy and/or curative chemotherapy will be recruited. The primary QoL outcome is measured using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-ELD14 mobility scale at 12 weeks. Secondary outcomes include overall and disease-free survival, treatment-related adverse events, and hospital admissions. We pre-powered this study to recruit 200 subjects based on the minimally clinically important difference for EORTC QLQ-ELD14 to achieve 80% statistical power (alpha 0.05), assuming 25% attrition. Outcomes will be analysed using intention-to-treat. Intervention consists of multi-domain comprehensive geriatric and supportive care assessments from a multidisciplinary team targeting unmet needs. These include functional decline, falls, incontinence, cognitive impairment, multi-morbidity, polypharmacy, and symptom relief, as well as social and psycho-spiritual concerns. Standard care entails routine oncological management with referral to geriatrics based on the discretion of the primary oncologist. Recruitment has been ongoing since August 2020. Results from the GOSPEL study will increase understanding of the impact of integrated geriatric and supportive care programs in older adults with cancer receiving curative treatment. Trial registration: This study is registered under ClinicalTrials.gov (ID NCT04513977)." @default.
- W4285603433 created "2022-07-16" @default.
- W4285603433 creator A5000704046 @default.
- W4285603433 creator A5004132064 @default.
- W4285603433 creator A5014538465 @default.
- W4285603433 creator A5025825032 @default.
- W4285603433 creator A5029077655 @default.
- W4285603433 creator A5048701628 @default.
- W4285603433 creator A5057544078 @default.
- W4285603433 creator A5076060242 @default.
- W4285603433 date "2023-01-01" @default.
- W4285603433 modified "2023-09-23" @default.
- W4285603433 title "Protocol for a randomised controlled trial on impact of comprehensive geriatric and supportive assessment versus standard care in older adults with cancer undergoing curative treatment: The Geriatric Oncology SuPportive clinic for ELderly (GOSPEL) study" @default.
- W4285603433 cites W1608689417 @default.
- W4285603433 cites W1904205969 @default.
- W4285603433 cites W1964375498 @default.
- W4285603433 cites W1982946927 @default.
- W4285603433 cites W1985776623 @default.
- W4285603433 cites W2006318999 @default.
- W4285603433 cites W2034878282 @default.
- W4285603433 cites W2035836995 @default.
- W4285603433 cites W2066258888 @default.
- W4285603433 cites W2076668534 @default.
- W4285603433 cites W2086628683 @default.
- W4285603433 cites W2103607521 @default.
- W4285603433 cites W2115930600 @default.
- W4285603433 cites W2126838184 @default.
- W4285603433 cites W2128529067 @default.
- W4285603433 cites W2149386818 @default.
- W4285603433 cites W2153836018 @default.
- W4285603433 cites W2159230388 @default.
- W4285603433 cites W2164186760 @default.
- W4285603433 cites W2553019438 @default.
- W4285603433 cites W2580525033 @default.
- W4285603433 cites W2592300154 @default.
- W4285603433 cites W2617857377 @default.
- W4285603433 cites W2645640394 @default.
- W4285603433 cites W2726760087 @default.
- W4285603433 cites W2749145009 @default.
- W4285603433 cites W2755829345 @default.
- W4285603433 cites W2767195694 @default.
- W4285603433 cites W2771006492 @default.
- W4285603433 cites W2781525129 @default.
- W4285603433 cites W2910964438 @default.
- W4285603433 cites W2912077170 @default.
- W4285603433 cites W2920054407 @default.
- W4285603433 cites W2922430335 @default.
- W4285603433 cites W2926544900 @default.
- W4285603433 cites W2953558819 @default.
- W4285603433 cites W2999205320 @default.
- W4285603433 cites W3006630083 @default.
- W4285603433 cites W3029388284 @default.
- W4285603433 cites W3046741173 @default.
- W4285603433 cites W3086264803 @default.
- W4285603433 cites W3087783401 @default.
- W4285603433 cites W3164449215 @default.
- W4285603433 cites W3172190198 @default.
- W4285603433 cites W3186267461 @default.
- W4285603433 cites W3202649090 @default.
- W4285603433 cites W3203086530 @default.
- W4285603433 cites W3209480926 @default.
- W4285603433 cites W2603116563 @default.
- W4285603433 doi "https://doi.org/10.1016/j.jgo.2022.07.002" @default.
- W4285603433 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35843845" @default.
- W4285603433 hasPublicationYear "2023" @default.
- W4285603433 type Work @default.
- W4285603433 citedByCount "0" @default.
- W4285603433 crossrefType "journal-article" @default.
- W4285603433 hasAuthorship W4285603433A5000704046 @default.
- W4285603433 hasAuthorship W4285603433A5004132064 @default.
- W4285603433 hasAuthorship W4285603433A5014538465 @default.
- W4285603433 hasAuthorship W4285603433A5025825032 @default.
- W4285603433 hasAuthorship W4285603433A5029077655 @default.
- W4285603433 hasAuthorship W4285603433A5048701628 @default.
- W4285603433 hasAuthorship W4285603433A5057544078 @default.
- W4285603433 hasAuthorship W4285603433A5076060242 @default.
- W4285603433 hasConcept C118552586 @default.
- W4285603433 hasConcept C121608353 @default.
- W4285603433 hasConcept C126322002 @default.
- W4285603433 hasConcept C159110408 @default.
- W4285603433 hasConcept C168563851 @default.
- W4285603433 hasConcept C1862650 @default.
- W4285603433 hasConcept C197934379 @default.
- W4285603433 hasConcept C27415008 @default.
- W4285603433 hasConcept C2777319248 @default.
- W4285603433 hasConcept C2779951463 @default.
- W4285603433 hasConcept C2994186709 @default.
- W4285603433 hasConcept C535046627 @default.
- W4285603433 hasConcept C54183767 @default.
- W4285603433 hasConcept C71924100 @default.
- W4285603433 hasConceptScore W4285603433C118552586 @default.
- W4285603433 hasConceptScore W4285603433C121608353 @default.
- W4285603433 hasConceptScore W4285603433C126322002 @default.
- W4285603433 hasConceptScore W4285603433C159110408 @default.
- W4285603433 hasConceptScore W4285603433C168563851 @default.
- W4285603433 hasConceptScore W4285603433C1862650 @default.
- W4285603433 hasConceptScore W4285603433C197934379 @default.
- W4285603433 hasConceptScore W4285603433C27415008 @default.